Richard W Mott has an estimated net worth of $24.5 Million. This is based on reported shares across multiple companies, which include KYPHON INC, TREACE MEDICAL CONCEPTS, INC., Lyra Therapeutics, Inc., and ENDOLOGIX INC /DE/.

2004 was Richard W Mott's most active year for acquiring shares with 11 total transactions. Richard W Mott's most active month to acquire stocks was the month of April. 2004 was Richard W Mott's most active year for disposing of shares, totalling 21 transactions. Richard W Mott's most active month to dispose stocks was the month of December. 2024 saw Richard W Mott paying a total of $694,864.48 for 198,451 shares, this is the most they've acquired in one year. In 2007 Richard W Mott cashed out on 1,175,000 shares for a total of $59,232,250.00, their largest year based on trade value.